CGT CUSTOMER SPOTLIGHTS
Customer Profile: uniQure
BACKGROUND uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. REQUIREMENTS FULFILLED BY SKYLAND PIMS® Low cost of ownership CPV solution to support lead [...]
Customer Profile: Alnylam
BACKGROUND Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. REQUIREMENTS FULFILLED BY SKYLAND PIMS® Data sharing among internal [...]
Customer Profile: Iovance
BACKGROUND Iovance Biotherapeutics aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune [...]
Customer Profile: Precision BioSciences
BACKGROUND Precision BioSciences (NASDAQ: DTIL) utilizes a proprietary genome editing method called ARCUS combined with a team made up of some of the leading minds and pioneers in [...]
Customer Profile: Autolus
BACKGROUND Autolus is at the forefront of a revolution in cancer treatment. Chimeric Antigen Receptor (CAR) T cell therapies have been shown to be effective in some haematological malignancies and may [...]
Customer Profile: Solid BioSciences
BACKGROUND Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy (Duchenne). They aim to be the center of excellence across the entire disease spectrum, serving as a [...]
Customer Profile: Sangamo Therapeutics
BACKGROUND Sangamo Therapeutics is a genomic medicine company conducting research & development across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo [...]
Customer Profile: bluebird bio
BACKGROUND bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. The company’s objective is to develop and bring the market [...]
Customer Profile: Histogenics
BACKGROUND Histogenics is a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function. Histogenics' technology platform has the potential to be used for [...]
